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Tail amputation by tail docking or as an extreme consequence of tail biting in commercial
pig production potentially has serious implications for animal welfare. Tail amputation
causes peripheral nerve injury that might be associated with lasting chronic pain. The
aim of this study was to investigate the short- and long-term effects of tail amputation
in pigs on caudal DRG gene expression at different stages of development, particularly
in relation to genes associated with nociception and pain. Microarrays were used to
analyse whole DRG transcriptomes from tail amputated and sham-treated pigs 1, 8, and
16 weeks following tail treatment at either 3 or 63 days of age (8 pigs/treatment/age/time
after treatment; n = 96). Tail amputation induced marked changes in gene expression
(up and down) compared to sham-treated intact controls for all treatment ages and time
points after tail treatment. Sustained changes in gene expression in tail amputated pigs
were still evident 4 months after tail injury. Gene correlation network analysis revealed two
co-expression clusters associated with amputation: Cluster A (759 down-regulated) and
Cluster B (273 up-regulated) genes. Gene ontology (GO) enrichment analysis identified
124 genes in Cluster A and 61 genes in Cluster B associated with both “inflammatory
pain” and “neuropathic pain.” In Cluster A, gene family members of ion channels e.g.,
voltage-gated potassium channels (VGPC) and receptors e.g., GABA receptors, were
significantly down-regulated compared to shams, both of which are linked to increased
peripheral nerve excitability after axotomy. Up-regulated gene families in Cluster B
were linked to transcriptional regulation, inflammation, tissue remodeling, and regulatory
neuropeptide activity. These findings, demonstrate that tail amputation causes sustained
transcriptomic expression changes in caudal DRG cells involved in inflammatory and
neuropathic pain pathways.
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INTRODUCTION
Tail docking, amputation of approximately half to two-thirds of
the tail, is a common practice in commercial pig production
in newly born piglets, as a preventative measure against
the issue of tail biting. This is an undesirable production-
related abnormal behavior performed by pigs reared under
sub-optimal environmental conditions and is often associated
with poor health status (1). However, even tail docking is
not a total safeguard against the loss of a portion of the tail
under conditions of severe tail biting, which means that pigs
can experience traumatic tail “amputation” through a portion
of the tail being bitten off later in life (2). Concerns exist
about the effects of tail amputation injury with respect to the
initiation of short (acute) and long-term (chronic) pain in the
tail stump (3–8). Tail amputation injury typically involves the
severing of the caudal nerves in the tail which lead to the
formation of “traumatic” or “amputation” neuromas in the
tail stump (9). Traumatic neuromas are defined as truncated,
tangled non-neoplastic proliferations of epineurial, perineurial,
and endoneurial connective tissue, Schwann cells and axons
which are attempting to regenerate after nerve transection
(10). In humans, the development of traumatic neuromas after
amputation-induced nerve injury can be a significant cause
of pain and is associated with the phenomenon of residual
stump pain and phantom limb pain, which is classified as a
neuropathic pain state (11, 12). Neuropathic pain is initiated
or caused by primary lesions to the somatosensory system.
This leads to structural and functional neuronal changes which
result in spontaneously occurring pain and amplified responses
to innocuous and noxious stimuli (13). Measurements on tail
amputated pigs carried out as part of this study, demonstrated
that tail amputation leads to traumatic neuroma development
and proliferation, that was still on-going 4 months after tail
amputation injury (4). This was associated with acute and long-
term changes in tail stump sensitivity, resembling neuropathic
pain (7).
Primary sensory neurons are responsible for the detection,
transduction, and transmission of painful and non-painful
stimuli. Their cell bodies (soma) reside in dorsal root ganglia
(DRG), from where they mediate axonal conduction of action
potential signals to the central nervous system via the dorsal
spinal cord (14). Peripheral nerve injury lowers the activation
threshold required to evoke action potential firing in primary
sensory neurons and can also cause spontaneous or ectopic
neuronal firing long after the removal of the stimulus (15–
17). Such changes in somatosensory nerve function are linked
to neuropathic pain and are commonly observed in traumatic
neuromas (18).
In the pig tail, sensory neurons are located in four caudal
nerves (two dorsal and two ventral, left and right) that innervate
all the way to the distal tip of the tail (19). The cell bodies
of the caudal nerve somatosensory neurons aggregate in four
corresponding DRG’s situated at the proximal confluence of
the cauda equina located within the sacrum, some distance
away from the region of tail amputation injury (ca. 7–9 caudal
vertebrae). Tail amputation injury in an appendage with this
level of sensory innervation is likely to cause acute and possible
long-lasting tail stump pain, especially where traumatic neuroma
development also present.
It has long been recognized that changes in pain sensitivity
and the presence of on-going chronic pain associated with
traumatic peripheral nerve injury are linked to marked changes
in the expression of neuropeptides and their receptors in primary
sensory neurons (20). A number of studies in rodents have
been undertaken investigating the effects of peripheral nerve
injury on changes in gene expression in DRG neurons (21–
25). From these studies it is clear that the pathophysiology
of neuropathic pain is complex and is linked to changes in
neurotransmission coupled to changes in immune activation and
neuroinflammation. It is currently not known if similar changes
occur in caudal nerve DRG sensory neurons in response to
tail amputation injury. Therefore, the aim of this study was to
investigate the transcriptional responses of the pig peripheral
nervous system to traumatic injury caused by tail amputation. In
particular, data analysis was undertaken to specifically examine
changes in DRG gene expression linked to inflammatory and
neuropathic pain signaling pathways.
MATERIALS AND METHODS
Animal and Housing
All animal procedures were carried out under license (PPL
70/7919) granted under the Animal (Scientific Procedures) Act
and approved by the Animal Welfare Ethical Review Boards of
Newcastle University and Scotland’s Rural College. Ninety-six
female pigs (Landrace/Large White x synthetic sire line) from a
resident herd at Cockle Park Farm, Newcastle University were
used in the study. The pigs were maintained under standard
housing conditions with ad libitum access to feed and water
from selection at the time of farrowing until 1 week prior to the
start of any experimental treatment. Optimal farrowing and post-
weaning pen temperatures were thermostatically maintained
throughout the duration of the experimental period.
Experimental Design (Animal)
In order to investigate the effects of tail amputation on
gene expression, 96 pigs were studied within a balanced,
factorial (2 × 2 × 3) study, incorporating two tail treatments:
(1) tail amputation and (2) sham amputation (intact tail
controls), two tail treatment ages (3 and 63 days), and three
post-tail-treatment times (+1, +8, and +16 weeks). This
experimental design provided 8 pigs/tail treatment/treatment
age/time after treatment.
Tail amputation was conducted on two groups of pigs at two
distinct ages: (1) 3 days post-natal, consistent with tail docking
of piglets in commercial pig production, and (2) 63 days of
age, concomitant with the age range associated with the onset
of severe tail biting in weaner pigs (26). In the study, animals
undergoing tail amputation at 63 days of age retained intact tails
until the time of surgical amputation of the tail under general
anesthesia. Animals identified with any tail biting or body injuries
at any time prior to experimental tail amputation treatment at 3
or 63 days were excluded from the study (n= 1: bitten tail).
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Tail Docking
Piglets were tail docked at 3 days of age in line with commercial
practice using a gas-heated docking iron (East Riding Farm
Services, Driffield, UK). Two-thirds of the tail was removed,
based on the measurement of intact tail length. Sham tail
amputated, control piglets were handled in the same way as
the tail docked animals but left with an intact tail. All docked
piglets were observed over the following weeks as part of routine
husbandry procedures for signs of post-amputation tail infection.
All amputated tail stumps appeared superficially to heal normally
without complications.
Surgical Tail Amputation Procedures
In pigs undergoing tail amputation at 63 days of age, such
tail removal had to be carried out under general anesthesia in
accordance with UK and European animal welfare regulations on
the protection of animal used for scientific purposes. Food was
withheld for a minimum of 8 h before surgical tail amputation.
On the day of surgery, pigs housed in one pen were collectively
transferred to a purpose-built pig holding unit equipped
with holding pens and a veterinary surgical theater. Prior to
surgery, animals were individually weighed and sedated using
an intramuscular combined injection of ketamine (5 mg/kg,
Vetoquinol, Buckingham, UK), midazolam (0.5 mg/kg, Hameln,
Gloucester, UK), and medetomidine (10 µg/kg, Vetoquinol,
Buckingham, UK). Following injection, the animals were left
undisturbed in an individual pen and transferred to the surgical
theater once adequate sedation was achieved, i.e., loss of righting
reflex. Each pig was placed in lateral recumbency on the operating
table covered with a thermostatically controlled heat blanket and
anesthesia was administered and maintained using isoflurane (3–
4%) (Abbot Laboratories Ltd, UK) delivered in 100% oxygen.
During anesthesia, blood O2 saturation and body temperature
were continually monitored. The tail length was measured to
determine the location of the site of amputation. The tail was
thoroughly cleaned and swabbed with 7.5% antiseptic povidone-
iodine solution (Ecolab, UK) and a tourniquet was placed at
the base of the tail to reduce blood flow. Loss of tail reflex
was verified before surgical amputation was performed using a
Liston bone cutter (World Precision Instrument, UK). Pinpoint
hemostasis was performed with a high temperature cautery
pen (Bovie Medical Corporation, USA) and wound powder
was applied to the amputated, distal tail stump. Once tail
resection was completed the pigs received an intramuscular
injection into the neck muscle of atipamezole (5 mg/kg,
Vetoquinol, UK), meloxicam (0.2 mg/kg, Boehringer Ingelheim,
UK), and Penicillin-Streptomycin (0.04 ml/kg, Norbrook, UK),
and anesthesia was ceased. At the end of the procedure, each
pig was covered with a thermal blanket and transferred to an
individual recovery penmeasuring 2× 2m containing deep clean
straw as bedding material and a water drinker. For 2 days after
tail surgery, pigs were housed individually in adjacent recovery
pens that allowed visual, auditory, and olfactory contact but
prevented physical interaction with other animals. The animals
designated to the “intact” treatment were exposed to the same
protocol, except for the amputation of a portion of the tail and the
administration of post-surgery drugs. The health of the animals
was continually monitored during recovery by a trained operator
along with regular inspections by the site veterinarians.
Sedation and Humane Killing
Post-mortem tissue collections were carried out on pigs 1,
8, and 16 weeks after tail treatment. Pigs were weighed to
determine the required doses for sedation and euthanasia and
sedated in a treatment pen with Stresnil (Azaperone 2 mg/kg;
Elanco Animal Health, UK) injected intramuscularly in the neck
and monitored over a 10–15min period until appropriately
sedated (immobile, absence of reaction to noise and tactile
stimulation). Once sedated, the ear vein was catheterized and
the animal was humanely killed by injection of Euthatal (sodium
pentobarbitone 150 mg/kg i.v.; Abbott Laboratories, Illinois,
USA). Once respiratory arrest and loss of corneal reflex was
confirmed, the pig was transferred a short distance (∼5m)
to a post-mortem room. Animals were exsanguinated and the
cadavers were plunged into a cold water bath for 5min to arrest
post-mortem metabolism.
Experimental Procedures (Tissue)
Tissue Dissection
Immediately following exsanguination and cold water
immersion, the pigs were rapidly dissected to collect the
caudal spinal cord and associated DRG. Once obtained, the
ensheathed spinal cord and DRG were transferred into a Petri
dish containing ice-cold sterile RNase/DNase free phosphate
buffered saline solution to chill and wash off any blood
contamination. The spinal cord and DRG were further dissected
under a stereo microscope to remove the meningeal membranes
to obtain the four caudal DRG corresponding to the four caudal
nerves and most distal part of the caudal spinal cord receiving
inputs from the DRG. All dissection equipment was carefully
washed with RNaseZap (Sigma-Aldrich, UK) before and after
use. Immediately following final dissection all tissues were placed
into sterile RNase/DNase-free 2ml cryotubes and snap frozen
in liquid nitrogen. All samples were stored at −80◦C prior to
RNA extraction.
Tissue RNA Extractions
DRG weights were determined prior to total RNA extraction
and tissues (∼30mg) were pooled placed into 2ml bead
homogenization tubes (Lysing matrix D—MP Biomedicals, UK)
with QIAzol reagent (1ml). DRG tissues were homogenized
using a FastPrep FP120 cell disrupter (Qbiogene Inc., France) for
3 × 40 s, replacing the tubes back on ice for ∼1min in between
homogenization bouts to prevent frictional heat build-up and
possible RNA degradation. The resulting homogenate was used
to prepare total RNA using the RNeasy Minikit (Qiagen, UK)
according to the manufacturer’s instructions (Qiagen RNeasy
Mini Kit handbook 6/2012). Preparation of RNA using this
spin column purification method included a DNase digestion
step to eliminate possible genomic DNA contamination. RNA
concentration and purity were determined by optical density
(A260/A280 and A260/A230 ratios) using a NanoDrop 1000
spectrophotometer (Thermo Scientific, USA). RNA integrity was
further evaluated using the RNA Screen tape assay (Agilent 2200
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TapeStation, Agilent technologies, Germany). An RNA integrity
number (RIN) for each sample was computed from a generated
electropherogram and software. All samples exhibited intact 28S
and 18S rRNA subunits with RIN ≥ 7.
Microarray Hybridization and Labeling
RNA labeling and hybridization were carried out by Edinburgh
Genomics, University of Edinburgh (https://genomics.ed.ac.uk/).
Total RNA (500 ng) was labeled using the WT Expression
Kit (P/N 4411974; Invitrogen, UK) to produce single stranded
cDNAwhich was labeled using the Affymetrix Terminal Labeling
Kit (P/N 900652; Affymetrix UK Ltd, UK). Approximately 3
µg of fragmented, biotin-labeled cDNA was hybridized to the
Affymetrix Porcine Gene 1.1 ST 96-Array Plate1 (394,580 probes;
22 median probes/gene; 19,212, gene-level probe sets) in the
GeneTitan Multi-channel (MC) instrument using the Affymetrix
standard protocols.
Data QC and Normalization
The .CEL files were loaded into Affymetrix Expression Console
Software for initial QC and to check for any outlier samples
prior to and after log2 robust multiarray averaging (RMA)
normalization of probe set intensity values.
Statistical Analysis
For differential expression analysis, the .CEL files were loaded
into Partek Genomics Suite (Partek Inc., USA) using the standard
gene expression workflow. The attributes for the individual
data files were identified and statistical comparisons of gene
expression were examined using a three-way analysis of variance
(ANOVA) incorporating tail treatment (sham vs. amputated),
time after treatment (1, 8, and 16 weeks), treatment age (3 vs.
63 days). The results from the 3-way ANOVA were subsequently
filtered to identify genes showing differential expression in
the contrasts set up (tail amputated vs. sham, controls). Only
those genes achieving a false discovery rate (FDR) cut-off of
0.05 were reported in the filtered gene lists. Contrast data
are presented as fold-change in transcript expression. A 3-way
ANOVA was also performed on probe-set signal intensity data
from selected genes derived from gene list enrichment analysis on
functional clustering of genes associated with inflammatory and
neuropathic pain. Data were analyzed using SAS software version
9.4 for windows (SAS Institute Inc., USA).
Network Co-expression Analysis
A Pearson correlation matrix was constructed using the network
analysis program Graphia Professional (Kajeka Ltd, Edinburgh,
UK), formally known as BioLayout Express3D (27), by comparing
the expression profile of each probe set with an average
expression >20 across all samples, to all others. A network
graph was constructed using a threshold value of r ≥ 0.75,
where nodes represent transcripts and the edges correlations
between transcripts above the threshold. The graph was then
clustered into co-expression clusters using the Markov clustering
algorithm (MCL) (28) using an inflation value of 2.2, which
determines the granularity of clustering. The profile of gene
1Genome build Sscrofa9 (susScr2).
clusters was inspected manually to find clusters whose expression
was associated with the experiment’s design and the biology of the
caudal DRG.
Functional Enrichment Analysis
The functional associations of gene clusters were examined
through Gene Ontology (GO) enrichment analysis using
ToppGene (29) (https://toppgene.cchmc.org/). GO terms
or pathways with a p < 0.05 were considered to be
significantly enriched.
RESULTS
Direct Link to Deposited Data
All .CEL files and normalized expression data files can be
accessed through the NCBI Gene Expression Omnibus (GEO)
international public repository (https://www.ncbi.nlm.nih.gov/
geo/GSE119519).
Differential Gene Expression
Significant differential gene expression (up and down) was
observed following tail amputation in both 3 and 63 day-old
pigs compared to respective sham treatment pigs (RMA 3-way-
ANOVA; p < 0.05; FDR = 0.05) in all of the time points after
tail treatment (i.e., still evident 16 weeks) after tail amputation
injury. Expression patterns and the total number of differentially
expressed transcripts varied within and between treatment age
and over time. Table 1 shows the number of differentially
expressed caudal DRG genes (up- and down-regulated) in a
comparison between tail amputated and sham treatment pigs
(range 119–3,794 genes). The total number of differentially
expressed genes varied between the two different tail treatment
age groups andwith time after tail treatment within treatment age
groups. The number of up- and down-regulated genes differed
within tail treatment age and with time after tail treatment.
The greatest number of genes exhibiting differential expression
(up and down) was observed 8 weeks after tail amputation
in both tail treatment age groups. Higher overall numbers of
differentially expressed DRG genes were observed in the 63 day
tail-amputated pigs compared to the 3 day-old treated pigs. An
Excel spreadsheet containing log2 fold change data and for all the
differentially expressed genes with RMA 3-way ANOVA p values
for main factor effects and 3-way interactions can be found in
Supplementary Data File 1.
Network Co-expression Analysis
A gene co-expression graph was generated where a Pearson
correlation threshold (r ≥ 0.75) was used to define relationships
between genes. The graph’s topology was highly structured
and comprised of 6,459 nodes (transcripts) and 232,125 edges
(correlations between expression profiles above the threshold).
Localized areas of high connectivity, representing groups of
genes with similar expression profiles, were defined using the
MCL graph clustering algorithm. Gene clusters represented the
different patterns of expression found within the data due to
the variability of treatment groupings, different ages of the
animals and sampling. Histograms of mean expression level of
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TABLE 1 | Total number of significant (P < 0.05) differentially expressed genes (up and down regulated) in caudal DRG neurons using an RMA 3-way-ANOVA contrast on
tail amputated vs. sham-treated pigs undergoing tail treatment at 3 (neonatal) and 63 (juvenile) days of age (1, 8, and 16 weeks after tail treatment) with false discovery
rate (FDR) = 0.05 applied (8* pigs/treatment/age/time).
Tail amputated vs. sham treatment
Treatment
age
Time after treatment Differentially expressed genes
(FDR = 0.05)
Up
regulated
Down
regulated
3 days 1 week 518 351 167
8 weeks 2,268 788 1,480
16 weeks 119 89 30
63 days 1 week 1,530 918 612
8 weeks 3,794 1,937 1,857
16 weeks 780 569 211
*Except for 63 day sham-treated T+1 week where n = 7 due to the removal of a tail bitten pig.
all genes within the 16 largest clusters (C1–C16) containing >50
transcripts are shown in Supplementary Figure 1.
Following inspection of the co-expression network, only two
clusters (A and B) we found to contain transcripts whose
expression was consistently down or up regulated in response
to treatment in both treatment age groups and across all three
time points after tail amputation (Figure 1). Cluster A (1), green
nodes, contains 759 transcripts whose expression was down-
regulated following tail docking and comprises many genes
associated with neurogenesis and neuronal function. Cluster B
(2), purple nodes, contains 273 transcripts upregulated following
tail docking and comprisingmany genes associated with response
to wound healing. All of the genes identified within both clusters
were consistently down- or up-regulated respectively, across all
time points after tail amputation and in both tail treatment age
groups. Log2 fold change gene expression values (tail amputation
vs. sham controls) in both treatment age groups and at each
time point after, and 3-way ANOVA p values for all Cluster A
(highlighted green) and Cluster B (highlighted purple) can be
found in Supplementary Data File 1.
Gene Ontology (GO) and Pathway
Enrichment Analysis
For each cluster the three most statistically enriched
gene ontologies (Biological Process) are shown in
Supplementary Figure 1, as analyzed using ToppGene. Of
the 16 largest clusters, clusters 6 and 10 contained mainly
unannotated genes for which no GO enrichment was obtained.
This high level analysis suggests that other gene clusters in
the data are associated with other variables, e.g., sampling of
ependymal cells (cluster 3), oxidative phosphorylation (cluster
4), extracellular matrix (cluster 5), mitotic division, lower at later
time points (cluster 9), interferon signaling (cluster 11), and
macrophages (cluster 15).
Enrichment analysis of genes in Cluster A and Cluster B
are shown for both clusters in Figure 2. The results for Cluster
A show a significant enrichment of molecular function GO
terms for primarily associated with passive and voltage- gated
ion transporter activity, ligand-gated ion transporter activity,
substrate-specific transporter activity, and cytoskeletal protein
binding. Cluster A genes GO biological process terms included
neurogenesis, regulation of neurogenesis, neuron differentiation
and development, axonogenesis, cell-to cell and synaptic signaling,
regulation of membrane potential, and neurotransmitter levels as
well as modulation of synaptic transmission. Genes enriched in
the GO cellular component analysis in Cluster A were associated
specifically with neuron and neuron components (e.g., axons,
dendrites, synapses) and membrane protein transporter and
receptor complexes.
GO enrichment analysis for Cluster B genes showed
significant enrichment of molecular function terms associated
with receptor binding, protein transcription activity and
regulation, G-protein alpha subunit binding, and neuropeptide
hormone activity. Enriched functional gene groupings identified
in Cluster B included those linked to GO biological processes
such as regulation of RNA biosynthesis, response to wounding,
and regulation of response to wounding, inflammatory response,
activation of the immune response and cell migration, cell
differentiation, regulation of cell migration and differentiation,
and well as the regulation of neuronal development and
survival. Genes revealed in the cellular component following GO
enrichment analysis were associated primarily with neuronal cells
and neuron projections and the somatodendritic compartment,
as well as some extracellular localization in other cell types,
e.g., macrophages.
DRG Genes Linked to Inflammatory and
Neuropathic Pain
As we have previously reported, tail amputation is associated
with sustained, reduced nociceptive mechanical thresholds (7)
and the development of traumatic neuromas (4) in the distal tail
stump. Both of these phenomena can be linked to inflammatory
or possible neuropathic pain. Therefore, we carried out a
further level of analysis on the up and down-regulated genes
identified in Clusters A and B. Gene lists for the GO terms
“inflammatory pain” and “neuropathic pain” were generated
from the GeneCards R© integrated database of human genes
(http://www.genecards.org/) for cross-reference with the porcine
microarray gene chip library and network analysis cluster
lists (see Supplementary Data Files 2, 3). GeneCards database
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FIGURE 1 | Network analysis of gene expression data. (A) Co-expression graph (r ≥ 0.75) with two clusters, A and B, highlighted. Cluster A (highlighted in green)
contains 759 transcripts whose expression was down-regulated following tail docking and comprising many genes associated with neuronal function. Cluster B
(highlighted in purple) contains 273 transcripts consistently upregulated following tail docking and comprising many genes associated with wound healing. (B)
Histograms of mean expression profiles for cluster A (green) and cluster B (purple), each bar representing data from a single animal.
FIGURE 2 | Ranks of significant gene ontology (GO) terms (p < 0.05 with Bonferroni correction) with number of genes in input within Clusters A and B for GO:
molecular function, GO: biological process, and GO: cellular component derived from gene list enrichment analysis using ToppGene analysis suite.
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generated an inflammatory pain list containing 2,630 genes and
a neuropathic pain list consisting of 477 genes (correct to April
2018). All of the genes identified in the network clusters that
were found in the inflammatory pain and neuropathic pain lists
were verified by cross-reference with peer-reviewed published
articles on peripheral nerve injury in the National Center for
Biotechnology Information (NCBI) PubMed records (https://
www.ncbi.nlm.nih.gov/pubmed/).
In Cluster A, a total of 124 pain-related genes were identified
from the two pain genes lists. Within this Cluster, 81 genes
were associated with inflammatory pain pathways and 16 genes
exclusively linked to neuropathic pain pathways, with 27 of the
expressed genes common to both pain states (Table 2). In cluster
B, 61 genes were identified in total from both pain gene lists.
Within this cluster, 48 genes were solely linked to inflammatory
pain with 12 genes common to both pain pathways and only
a single gene associated with neuropathic pain signaling. These
genes were then selected for closer examination.
Cluster A (Neuronal Function): Inflammatory and
Neuropathic Pain Genes
Within network Cluster A, ∼16% of the significant differentially
expressed DRG genes changing in response to tail amputation
were linked to the processes of pain signal detection, conduction,
transmission, and modulation as determined by GO gene
set enrichment analysis. GO term analysis identified several
common functional families of genes involved pain signaling
pathways these included: ion channels, transporters and
receptors such as voltage-gated potassium channels and
potassium ion leak channels, voltage-activated sodium channels,
voltage-dependent calcium channels, cation transporters, solute
carrier membrane transporters, gamma-aminobutyric acid
(GABA) receptors, metabotropic glutamate receptors, cholinergic,
adenosine, purinergic receptors, and opioid receptors.
DRG probe-set signal intensity plots for the genes illustrated
in Table 3 from sham and tail amputated pigs shown over
time and in both tail amputation age groups are presented in
Figures 3–7. A three-way ANOVA table of all p values and F-
ratios generated from a test of fixed effects with interactions for
all of the highlighted Cluster A genes shown in Figures 3–7 can
be found in Supplementary Data 4.
Voltage-gated potassium channels
The role of voltage-gated potassium channels (VGPC) in pain
signaling is widely recognized (30). Forty mammalian VGPC
genes have been discovered (31) of which 6 VGPC subfamily
gene subunits have been linked to inflammatory and neuropathic
pain. Twenty-six VGPC subunit genes were screened on the
Affymetrix porcine gene array of which 8 subunit genes identified
in Cluster A. Figures 3A–F show the probe-set intensity
profiles of the 8 VGPC subunit genes identified in Cluster A,
representing 6 channel sub-families (A-, G-, Q-, H-, V-, and T-
type) exhibiting sustained reductions in transcript expression in
response to tail amputation. Sustained and significant reductions
in signal intensities were also observed in two K-type two-pore
domain potassium leak channel genes (KCNK1 and KCNK10) in
response to tail amputation (Figures 3G,H). These leak channels
contribute to passive transmembrane potassium transport and
play a key role in regulation of neuronal excitability (32).
TABLE 3 | Functional groups, family member/subunit, and their associated
significantly (3-way ANOVA; p < 0.05) down-regulated DRG pain genes* after tail
amputation in network Cluster A common to GeneCard inflammatory and
neuropathic pain gene lists.
Functional
group
Member/subunit Gene symbol
Ion channel Potassium (K+) channel subunit KCNA4, KCNG4, KCNQ3,
KCNH6, KCNV1, KCNT2,
KCNK1, KCNK10
Sodium (Na+) channel subunit SCN1A, SCN4B
Calcium (Ca2+) channel subunit CACNA1A, CACNA2D
Acid sensing proton (H+)
channel
ASIC
ATPase Na+/K+ subunit ATP1A1
Solute
transporter
Organic anion transporter family
member
SLCO5A1
Na+/Ca2+ exchanger family
member
SLC8A2
Na+/H+ exchanger family
member
SLC9A9
Receptor Gamma-aminobutyric acid
(GABA) receptor subunit
GABRB2, GABRB3, GABBR1,
GABBR2
Metabotropic glutamate receptor GRM4, GRM8
Cholinergic receptor subunit CHRNA3, CHRNB4, CHRM4
Purinergic receptor P2RY14
Adenosine receptor ADORA1
Opioid receptor OPRM1
*Consistently down-regulated across all time points after tail amputation (T+1, T+8, and
T+16 weeks) and common to both tail treatment age groups (3- and 63-days).
TABLE 2 | Inflammatory pain and neuropathic pain genes* expressed in network Cluster A (neuronal function) and Cluster B (wound healing).
Significant differentially expressed genes (p < 0.05)
Network cluster Inflammatory pain Neuropathic pain Common
to both lists
Total
Cluster A (759 genes) 81 16 27 124
Cluster B (273 genes) 48 1 12 61
*Lists for inflammatory pain (2,630) and neuropathic pain (477) genes were generated from GeneCards® Human gene database (correct to April 2018) and confirmed by cross-reference
against citations on peripheral nerve injury in the National Center for Biotechnology Information (NCBI) PubMed biomedical literature database.
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FIGURE 3 | Probe-set signal intensities of selected significantly down-regulated DRG voltage-gated potassium channel genes after tail amputation in network Cluster
A associated with inflammatory and neuropathic pain signaling. (A) KCNA4, Potassium voltage-gated channel subfamily A member 4; (B) KCNG4, Potassium
(Continued)
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FIGURE 3 | voltage-gated channel modifier subfamily G Member 4; (C) KCNQ3, Potassium voltage-gated channel subfamily Q member 3; (D) KCNH6, Potassium
voltage-gated channel subfamily H Member 6; (E) KCNV1, Potassium voltage-gated channel modifier subfamily V member 1; (F) KCNT2, Potassium
sodium-activated channel subfamily T member 2; (G) KCNK1, Potassium two pore domain channel subfamily K member 1; (H) KCNK10, Potassium two pore domain
channel subfamily K member 10. All signal intensity data values are shown by treatment group (open circles, n = 95) along with group mean ± SEM.
FIGURE 4 | Probe-set signal intensities of selected significantly down-regulated DRG ion channel genes after tail amputation in network Cluster A associated with
inflammatory and neuropathic pain signaling (A) SCN1A, Sodium voltage-gated channel alpha subunit 1; (B) SCN4B, Sodium voltage-gated channel beta subunit 4;
(C) CACNA1A, Calcium voltage-gated channel subunit alpha 1A; (D) CACNA2D2, Calcium voltage-gated channel auxiliary subunit alpha 2 delta 2; (E) ATP1A1,
ATPase Na+/K+ transporting subunit alpha 1; (F) ASIC1, Acid sensing (proton-gated) ion channel subunit 1. All signal intensity data values are shown by treatment
group (open circles, n = 95) along with group means ± SEM.
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FIGURE 5 | Probe-set signal intensities of selected solute carrier (SLC) sub-type DRG genes significantly down-regulated after tail amputation in network Cluster A
associated with inflammatory and neuropathic pain signaling pathways. (A) SLCO5A1, Solute carrier organic anion transporter family 5 member A1; (B) SLC8A2,
Solute carrier family 8 member A2 (sodium/calcium exchanger); (C) SLC9A9, Solute carrier family 9 Member A9 (sodium/proton exchanger); (D) SLC17A8, Solute
carrier family 17 Member 8 (sodium-dependent inorganic phosphate co-transporter); (E) SLC24A2, Solute carrier family 24 Member A2 (sodium/potassium/calcium
exchanger); (F) SLC25A22, Solute carrier family 25 Member 22 (mitochondrial carrier: glutamate). All signal intensity data values are shown by treatment group (open
circles, n = 95) along with group means ± SEM.
Voltage-gated sodium channels
Voltage-gated sodium-selective ion channels (VGSC) are present
in the membrane of most excitable cells comprising a pore-
forming α-subunit associated with either one or two β-subunits
(33). The role of VGSC in neuropathic pain is still unclear as
peripheral nerve injury down regulates most pain associated
voltage channels in the injured DRG neurons (34). Genes coding
for 9 α-subunits and 4 β-subunits have been identified in
mammals. Probe-sets for 3 α-subunits and 2 β-subunits were
present on the porcine microarray. Of these only SCN1A and
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FIGURE 6 | Probe-set signal intensities of significantly down-regulated DRG gamma-aminobutyric acid (GABA) receptor genes after tail amputation in network Cluster
A associated with inflammatory and neuropathic pain signaling (A) GABRB2, Gamma-aminobutyric acid type A receptor beta 2 subunit; (B) GABRB3,
Gamma-aminobutyric acid type A receptor beta 3 subunit; (C) GABBR1, Gamma-aminobutyric acid type B receptor subunit 1; (D) GABBR2, Gamma-aminobutyric
acid type B receptor subunit 2. All signal intensity data values are shown by treatment group (open circles, n = 95) along with group means ± SEM.
SCN4B were identified in Cluster A (Figures 4A,B). Probe-
set signal intensities for both channel subunit genes were
significantly lower (p< 0.05) in response to tail treatment at both
ages and over time compared to sham controls.
Voltage-gated calcium channels
Voltage-gated calcium channels (VGCC) are involved in the
mediation of pain perception through the modulation of
neurotransmitter release at presynaptic terminals of DRG
sensory neurons (35). The channels are comprised of either 4
or 5 distinct subunits coded by multiple genes (36). To date
10 subunit genes have been identified in humans (37) of which
probe-sets for 7 channel subunit genes were present on the pig
array. Two subunit genes were present in network Cluster A of
which CACNA1A and regulatory auxiliary subunit CACNA2D2
are shown in Figures 4C,D. Probe-set signal intensities for both
subunit genes were significantly lower (p < 0.05) in response
to tail treatment at both ages, and over time compared to sham
controls, consistent with other down-regulated genes in the
Cluster A expression profile.
Other ion channels
ATPase Na+/K+ transporting subunit alpha 1 (ATP1A1). The
protein encoded by this gene belongs to the family of P-type
cation transport ATPases, and to the subfamily of Na+/K+
ATPases (38). Na+/K+ -ATPase is an integral membrane protein
responsible for establishing and maintaining the electrochemical
gradients of Na and K ions across the plasma membrane and
have been implicated in mechanisms of neuropathic pain (23).
Seven genes coding for 4 α- and 3 β-channel subunits have
been characterized of which 6 subunits present were on the
array. One subunit gene ATP1A1 was present in network Cluster
A (Figure 4E). Probe set signal intensities for this gene were
markedly lower (p < 0.05) in response to tail treatment at
both ages and over time compared to sham controls. Another
down-regulated ion channel gene identified in Cluster A was
acid sensing proton-gated ion channel subunit 1 (ASIC1). Acid-
sensing ion channels are neuronal voltage-insensitive cation
channels activated by extracellular protons (H+) and are involved
in neurotransmission in inflammation and neuropathic pain
conditions (39). Five subunit genes have been identified for this
family of channels. ASIC1 was the only one of the subunit genes
Frontiers in Veterinary Science | www.frontiersin.org 11 September 2019 | Volume 6 | Article 314
Sandercock et al. Porcine DRG Pain Genes Analysis
FIGURE 7 | Probe-set signal intensities of selected significantly down-regulated DRG genes expressing G-protein-coupled neurotransmitter receptors after tail
amputation in network cluster A associated with inflammatory and neuropathic pain signaling (A) GRM4, Glutamate metabotropic receptor 4; (B) GRM8, Glutamate
(Continued)
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FIGURE 7 | metabotropic receptor 8; (C) CHRNA3, Cholinergic receptor nicotinic alpha 3 subunit; (D) CHRNB4, Cholinergic receptor nicotinic beta 4 subunit; (E)
CHRM4, Cholinergic receptor muscarinic 4; (F) OPRM1, Glutamate metabotropic receptor 8; (G) ADORA1, Adenosine A1 receptor; (H) P2RY14, Purinergic receptor
P2Y14. All signal intensity data values are shown by treatment group (open circles, n = 95) along with group means ± SEM.
found on the array and in common with all of the other ion
channels co-expressed in Cluster A exhibited significantly lower
(p < 0.05) microarray probe set signal intensities in response
to tail treatment at both ages and over time compared to sham
equivalents (Figure 4F).
Solute carrier membrane transporters
The solute carrier (SLC) group of membrane transport proteins
include over 400 members organized into over 60 families
(40). Recent research has highlighted solute carrier transporters
as emerging therapeutic targets in inflammatory diseases such
as inflammatory bowel disease (41). Over 170 SLC genes
were on the porcine array of which 18 with sustained
and significant reductions (p < 0.05) in gene probe set
intensities were identified in Cluster A. Six of these genes
(SLCO5A1, SLC8A2, SLC9A9, SLC17A8, SLC24A2, SLC25A22)
are highlighted in Figures 5A–F, representing key SLC subfamily
members associated with anionic, cationic, excitatory amino acid
and mitochondrial ADP/ATP transport.
Gamma aminobutyric acid (GABA) receptors
The roles of the inhibitory neurotransmitter gamma amino
butyric acid (GABA) and its receptors in nociceptive signal
processing and pain are well-recognized (42). Nineteen
ionotropic type A (GABA AR) and two metabotropic type B
(GABA BR) receptor subunit genes have been identified of which
7 type A and both type B receptors probe sets were present
on the microarray. Two ionotropic (GABRB2, GABRB3) and
both metabotropic (GABBR1, GABBR2) receptor subunits were
significantly down-regulated in Cluster A (Figures 6A–D).
Probe-set intensity values for all of the DRG GABA-R subunit
genes were significantly lower (p < 0.05) in response to tail
treatment at both ages and over time compared to sham controls.
Metabotropic glutamate receptors
Glutamate is a major amino acid that functions as an
excitatory neurotransmitter in pain pathways (43). Eight genes
for metabotropic G-protein coupled glutamate receptors have
been determined in mammals of which 4 had probe sets
on the microarray. In Cluster A, the expression of two
metabotropic glutamate receptor genes (GRM4 and GRM8) was
significantly down-regulated (p < 0.05) as a consequence of
tail amputation (Figures 7A,B). The down-regulation in gene
expression reflected by the sustained reduction in probe set
intensity values was still evident ca. 4 months after tail treatment
at 3 and 63 days of age in comparison to the shams.
Nicotinic and muscarinic acetylcholine receptors
Nicotinic acetylcholine receptors (nAChRs) are cholinergic
receptors that form ligand-gated ion channels in pre- and
postsynaptic neural membranes that are produced by 16 genes
that code for 5 receptor subunits (α, β, δ, ε, γ) (44). In the
present study probe sets for 10 genes were present on the array
of which two neuronal specific genes (CHRNA3 and CHRNB4)
were observed in the Cluster A co-expression network. Probe-set
intensity values for both nAChR subunit genes were significantly
lower (p < 0.05) in response to tail amputation treatment at both
ages and over time compared to sham controls (Figures 7C,D).
In addition a single muscarinic acetylcholine receptor gene
(CHRM4) was also found to be down regulated in the DRG
Cluster A as a consequence of tail amputation (Figure 7E).
Muscarinic acetylcholine receptors (mAChRs) are receptors that
form G protein-receptor complexes in the cell membranes
of neurons and possess a regulatory effect on dopaminergic
neurotransmission (45). Five genes have been identified of which
only probe-sets for CHRM4 were present on the array.
Opioid receptors
It is well-recognized that exogenous and endogenous opioids and
their opioid receptors play a major role in pain relief (46, 47).
Three genes coding for 3 opioid receptors (mu, delta, kappa)
have been identified in mammals (48). Probe sets for two of
those genes OPRM1 and OPRK1 coding for opioid receptors mu
and kappa, respectively, were present on the array. Of these only
OPRM1 was present in network Cluster A (Figure 7F). Probe-
set intensity values forOPRM1were significantly and persistently
lower (p < 0.05) in response to tail amputation at both ages and
over time compared to sham controls.
Adenosine receptors
The antinociceptive actions of adenosine and it’s receptors on
pain modulation is widely recognized (49). Four genes coding for
adenosine receptors have characterized in mammals. Probe sets
for 3 of those genes were present on the gene array. Only one
of the genes ADORA1 occurred in Cluster 1 (Figure 7G) and in
common with all of the other Cluster A DRG genes exhibited a
significant reduction (p < 0.05) in probe set signal intensity as a
consequence of tail amputation that was sustained up to 4months
in both treatment age groups.
P2Y purinergic receptors
Metabotropic P2Y receptors play a crucial role in facilitating
pain transmission at peripheral and spinal sites (50). There are
eight known genes coding for P2Y receptor. In the current study,
there were probe sets for 6 of the P2Y receptor genes of which
P2YR14 was identified in network Cluster A (Figure 7H). DRG
P2YR14 gene signal intensities were significantly lower in the tail
amputated animal compared to controls in both treatment age
groups. Lowered signal intensities were still evident at 16 weeks
after tail treatment (p < 0.05).
Cluster B (Wound Healing): Inflammatory and
Neuropathic Pain Genes
Within network Cluster B the majority of significant,
differentially expressed DRG genes changing in response to
tail amputation treatment and linked to inflammatory and
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TABLE 4 | Functional groups, subgroups, and their associated significantly (3-way
ANOVA; p < 0.05) up-regulated DRG pain genes* after tail amputation in network
Cluster B common to GeneCard inflammatory and neuropathic pain gene lists.
Functional
group
Member Gene symbol
Transcription
factor
Activating transcription factor 3 ATF3
Jun proto oncogene JUN
Neuropeptide Proenkephalin PENK
Somatostatin SST
Galanin/GMAP propeptide GAL
Neuropeptide Y NPY
Adenylate cyclase activating
polypeptide
ADCYAP1
Inflammatory
intermediate
Phospholipase A2 group III PLA2G3
Prostaglandin-endoperoxide
synthase 2
PTGS2
Interleukin 24 IL24
Receptor 5-Hydroxytryptamine (serotonin)
receptor
HTR2A
Angiotensin II receptor AGTR2
Neuromedin U receptor NMUR2
Neuropeptide S receptor NPSR
Neurotrophin receptor tyrosine
kinase
NTRK3
Interleukin 4 receptor IL4R
*Consistently up-regulated across all time points after tail amputation (T+1, T+8, and
T+16 weeks) and common to both tail treatment age groups (3- and 63-days).
neuropathic pain pathways were common to several GO term
functional gene families associated with transcription factor
activity, DNA binding transcription factor activity, regulation
of DNA binding transcription factor activity, polymerase II
transcription factor activity, sequence-specific DNA binding,
transcription from RNA polymerase II promoter, protein
homodimerization activity, immune response, immune cell
proliferation and migration inflammatory response, regulation of
the inflammatory response, wound healing, peptidase inhibitor
activity, protein tyrosine kinase activity, activation of adenylate
cyclase activity, receptor binding, signal transducer activity,
neurotrophin signaling pathway, neuropeptide signaling pathway,
neuronal survival, neuron development and migration, potassium
channel activity.
Pig DRG pain genes identified in Cluster B that were
consistently up-regulated at all three time points (1, 8, and 16
weeks) after tail amputation and common to both tail amputation
groups (3-days and 63-days) are shown in Table 4. DRG probe-
set signal intensity plots for the genes illustrated in Table 3 from
sham and tail amputated pigs shown over time and in both
tail amputation age groups are presented in Figures 8–11. A
three-way ANOVA table of all p values and F-ratios generated
from a test of fixed effects with interactions for all of the
highlighted Cluster B genes shown in Figures 8–11 can be found
in Supplementary Data 5.
Transcription factors
DRG probe-set signal intensities of activating transcription factor
3 (ATF3; Figure 8A) and Jun proto-oncogene, AP-1 transcription
factor subunit (JUN; Figure 8B) were significantly up regulated
(p < 0.05) in Cluster B and remained increased up to 16 weeks
after tail injury in both treatment age groups compared to sham-
treated controls. Both transcription factors are associated with
inflammatory and neuropathic pain conditions linked to nerve
injury (51, 52).
Arachidonic acid metabolism intermediates
Arachidonic acid is a key inflammatory intermediate and its
conversion into a wide range of clinically important bioactive
compounds (eicosanoids) involved in the generation and
maintenance of inflammatory pain is well-documented (53, 54).
Within the DRG Cluster B network, signal intensities for the
phospholipase A2 group III (PLA2G3) a gene that encodes
for secreted phospholipase A2 enzyme which catalyses the
hydrolysis of phospholipids to release of arachidonic acid and
lysophospholipids was significantly higher (p < 0.05) in the
tail amputated vs. sham treated controls in both treatment
age groups (Figure 8C). Similarly, probe-set signal intensities
for prostaglandin-endoperoxidase synthase 2 (PTGS2), were
significantly higher (p < 0.001) in both tail amputated
groups. Again, these increases were sustained up to 16 weeks
after tail injury (Figure 8D). PTGS2 codes for the enzyme
prostaglandin-endoperoxidase synthase which is formally known
as cyclooxygenase 2 (COX-2) a key tissue-injury inducible
enzyme in prostanoid biosynthesis involved in inflammation and
mitogenesis (55).
Peptidase inhibitors
Specific inhibitors of neuronal proteases known as serpins are
postulated to play a key role in neuronal survival, synaptic
plasticity and axonal development, regeneration, and the
amelioration of neuropathic pain (56, 57). In this study within
the DRG genes identified in network Cluster 6, signal intensities
for the Serpin family B member 2 (SERPINB2; Figure 8E) were
highly and significantly elevated in both tail treatment age groups
compared to sham controls (p < 0.001). Signal intensities of
tissue inhibitor of metalloproteinases 1 (TIMP1, Figure 8F) were
also significantly increased in tail amputated vs. sham control
DRGs in both tail treatment ages (p < 0.05). A significant time-
related reduction in signal intensity expression at 16 weeks was
observed in both tail amputation group compared to T+1 week
(p < 0.05). Transcription of this gene is highly inducible in
response to peripheral nerve injury (58) and it has been suggested
that TIMP1 and other TIMP proteins may have therapeutic
potential for the treatment of neuropathic pain (59).
Endogenous neuropeptides
Probe set intensities for genes of several key endogenous
neuroactive peptide ligands involved in pain signal modulation
in DRG neurons were significantly increased (p < 0.001)
after tail amputation compared to sham controls in both tail
treatment age groups (Figures 9A–D). These included genes
coding for proenkephalin (PENK, Figure 9A), galanin and
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FIGURE 8 | Probe-set signal intensities of DRG genes in network Cluster B involved in inflammatory and neuropathic pain pathways expressing significant
up-regulated transcript activity (3-way ANOVA, p < 0.05) 1, 8, and 16 weeks after tail amputation at two ages (3 and 63 days). Genes shown are linked to regulation
of gene expression, inflammation, proteinase inhibition, and neurotropic signaling. (A) ATF3, Activating transcription factor 3; (B) JUN, Jun proto-oncogene, AP-1
transcription factor subunit; (C) PLA2G3, Phospholipase A2 group III; (D) PTGS2, Prostaglandin-endoperoxide synthase 2; (E) SERPINB2, Serpin family B member 2;
(F) TIMP1, TIMP metallopeptidase inhibitor 1. All signal intensity data values are shown by treatment group (open circles, n = 95) along with group means ± SEM.
GMAP prepropeptide (GAL; Figure 9B), somatostatin (SST;
Figure 9C) neuropeptide Y (NPY ; Figure 9D), Interleukin-24
(IL24; Figure 9E), and adenylate cyclase activating peptide 1
(ADCYAP1; Figure 9F).
The PENK gene encodes for a preproprotein that is
proteolytically processed to generate multiple neuropeptide
products that include the opioids Met-enkephalin and
Leu-enkephalin, which are stored in synaptic vesicles
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FIGURE 9 | Probe-set signal intensities of selected up-regulated DRG genes in response to tail amputation in network Cluster B encoding for endogenous
neuroactive peptides involved in the modulation of inflammatory and neuropathic pain signaling. (A) PENK, Proenkephalin; (B) GAL, Galanin and GMAP
Prepropeptide; (C) SST: Somatostatin; (D) NPY, Neuropeptide Y; (E) IL24, Interleukin-24; (F) ADCYAP1, Adenylate cyclase activating peptide 1. All signal intensity
data values are shown by treatment group (open circles, n = 95) along with group means ± SEM.
and released into the synapse where they bind to mu-
and delta-opioid receptors to modulate the perception
of pain (60). PENK mRNA and its post-translational
products have also been detected in immune cells
and been shown to play a key role in the modulation
of pain signaling in the peripheral sensory nervous
system (61).
The GAL gene is widely expressed in peripheral and
central nervous system and codes for a precursor protein
that is proteolytically processed to generate two mature
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FIGURE 10 | Probe-set signal intensities of selected significantly up-regulated DRG genes in network Cluster B encoding for G-protein coupled and interleukin
receptors involved in the mediation of inflammatory and neuropathic pain. (A) HTR2A, 5-Hydroxytryptamine receptor 2A; (B) AGTR1, Angiotensin II receptor type 1;
(C) NMUR2, Neuromedin U receptor 2; (D) NPSR1, Neuropeptide S receptor 1; (E) NTRK3, Receptor tyrosine kinase 3; (F) IL4R, Interleukin 4 receptor. All signal
intensity data values are shown by treatment group (open circles, n = 95) along with group means ± SEM.
peptides: galanin and galanin message-associated peptide
(GMAP). Galanin has diverse physiological functions
including nociception, learning and memory (62, 63).
GMAP mirrors galanin expression being derived from the
same precursor protein and but unlike galanin may have a
limited role in modulating nociceptive signals after nerve
injury (64).
SST gene codes for a preprotein that is subsequently cleaved
to produce the cyclic neuropeptide hormone somatostatin
(formerly known as somatotropin release inhibiting factor). It is
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FIGURE 11 | Probe-set signal intensities of significantly up-regulated DRG genes in network Cluster B in response to tail amputation involved in the mediation of
inflammatory and neuropathic pain signaling. (A) KCNK3, Potassium two pore domain channel subfamily K member 3 and neuronal high affinity glutamate transporter;
(B) SLC1A1, Solute carrier family 1 member 1. All signal intensity data values are shown by treatment group (open circles, n = 95) along with group means ± SEM.
an abundant neuropeptide and has a wide range of physiological
effects on neurotransmission, secretion, and cell proliferation
(65). Somatostatin has been shown to have anti-nociceptive and
anti-inflammatory effects and markedly inhibits cross-excitation
exerted by the release of excitatory neurotransmitters such as
glutamate and substance P (66, 67).
Within the Cluster B pain genes there was also observed a
sustained and significant increase in probe-set signal intensities
for the neuropeptide Y gene (NPY) in both tail amputated
groups (p < 0.05). Neuropeptide Y (NPY) the neuropeptide
hormone expressed in peripheral DRG neurons can have both
anti- and pro-nociceptive effects depending upon its end target
receptor location (68). These authors also suggest that NPY and
galanin may work together in partnership in the modulation of
neuropathic pain caused by severe peripheral nerve injury (69).
The role of pro- and anti-inflammatory cytokines has
long been recognized in inflammatory and neuropathic pain
conditions (70, 71). In the present study highly significant initial
increases (T+1 week) in DRG probe set intensities for the gene
coding for interleukin-24 (IL24) were observed (Figure 9E) in
the two tail-amputated groups compared to their respective
sham-handled controls (p < 0.05). This initial increase appeared
to attenuate over time but still remained significantly elevated
compared to controls at 8 and 16 weeks following tail resection
injury. Interleukin-24 (IL-24) is a member of the IL-10 family
of cytokines and is primarily produced in peripheral blood
mononuclear cells but also found in keratinocytes, melanocytes,
fibroblasts and other tissues. It plays a key role in inflammatory
and antibacterial immune responses, tissue remodeling, wound
healing, anti-tumor effects (72).
Adenylate cyclase activating peptide 1 (ADCYAP1)
encodes the pro-protein pituitary adenylate cyclase-activating
polypeptide (PACAP) a multifunctional neuropeptide belonging
to the glucagon-secretin-vasoactive intestinal peptide (VIP)
family (73). PACAP stimulates adenylate cyclase and increases
cyclic adenosine monophosphate (cAMP) levels, resulting in the
transcriptional activation of target genes. The products of this
gene are recognized as key mediators of neuroendocrine stress
responses (74). DRG probe set intensities for the ADCYAP1
gene were significantly elevated (p < 0.05) and remained
elevated up to 4 months after tail amputation treatment in
both tail treatment age groups compared to sham handled pigs
(Figure 9F). Axotomy induced increases in ADCYAP1 gene
expression have been previously reported facial motor nucleus
neurons (75) and it has been suggested that the encoded PACAP
protein may play a physiological role as a neurotransmitter or
neuromodulator in sensory C-fiber pain signaling (76).
5-hydroxytryptamine (serotonin) receptors
After nerve injury, the serotonin content of the lesioned nerve
increases, concomitant with this is an increase in several neuronal
5-HT receptors (77). Thirteen 5-HT receptor sub-type genes
have been identified of which 6 were present on the Affymetrix
array. In this study, there were significant increases (p < 0.05) in
DRG gene probe set intensities for 5-HT receptor 2A (HTR2A)
in the tail amputated groups compared with shams in both
tail treatment ages Figure 10A). Increased 5-HT2A receptor
expression in DRG neurons has been linked to the potentiation
of inflammatory pain signaling in the peripheral nervous system
and may also be involved in the development of neuropathic
pain (78). 5-HT acting in combination with other mediators can
ectopically excite and sensitize afferent nerve fibers contributing
to peripheral sensitization and hyperalgesia in inflammation and
nerve injury (77).
Angiotensin II receptors
Angiotensin receptors are a class of G protein-coupled receptors
with angiotensin II as their primary ligand. They are responsible
for the signal transduction of the vasoconstriction stimulus
of the main effector hormone, angiotensin II. There are two
genes contained within this family angiotensin I receptor type I
(AGTR1) and II (AGTR2). Probe sets for both genes were present
on the microarray but only AGTR1 was present in the network
Cluster B pain genes list (Figure 10B). Signal intensities for
Frontiers in Veterinary Science | www.frontiersin.org 18 September 2019 | Volume 6 | Article 314
Sandercock et al. Porcine DRG Pain Genes Analysis
AGTR1were significantly higher over the duration of the study in
the two tail amputated groups at 3 and 63 days compared to sham
controls (p < 0.05). AGTR1 mRNA has previously been shown
to be markedly elevated in response to peripheral nerve injury
by crushing or axotomy (79) and its coded receptor, angiotensin
II type 1 receptor (AT1) is believed to be involved in Schwann
cell-mediated myelination and in neuroregenerative response in
DRG neurons.
Neuromedin U receptors
The neuromedin U receptors are two G-protein coupled
receptors which bind the neuropeptide hormone neuromedin U
(80). There are two subtypes of the neuromedin U receptor, each
encoded by a separate gene (NMUR1, NMUR2). Only NMUR2
was present on the array chip and it was also subsequently
identified in the Cluster B correlation network.NMUR2 exhibited
large and sustained increases in gene probe set signal intensities
in the tail amputated groups (p < 0.05) compared with sham
controls in the two tail treatment ages (Figure 10C). Neuromedin
U (NMU) has been reported to be involved in the modulation of
spinal nociceptive reflexes through its interaction with the NMU
type 2 receptor in spinal dorsal horn neurons (81).
Neuropeptide S receptor
Neuropeptide S receptor (NPSR) belongs to the G-protein
coupled receptors (GPCR) family and it binds neuropeptide S
(NPS) which has several biological actions depending upon the
cell type and location (82). In the central nervous system, the
NPS-NPSR system promotes anxiolytic-like effects (83), whereas
in spinal nervous systems and peripheral tissues it appears to
be involved in the modulation of chemotaxis and inflammation
(84, 85) and nociception (86). DRG neuropeptide S receptor
1 (NPSR1) gene probe-set signal intensities were significantly
increased (p < 0.05) and remained increased up to 16 weeks after
tail amputation in the two different tail treatment age groups
compared to sham-handled controls, although signal intensities
for NPSR1 appeared to reduce over time in the neonatal tail
amputated piglets compared to the juvenile tail amputated
pigs (Figure 10D).
Neurotrophin receptors
Receptor tyrosine kinases (RTKs) represent a key family of
cell-surface receptors, which transduce signals to neuropeptides,
hormones, cytokines and growth factors, which in neurons are
involved in numerous cellular processes including neuronal
differentiation and proliferation, survival and metabolism,
axonal guidance, and cell cycle control (87). Neurotrophic
receptor tyrosine kinase 3 (NTRK3; Figure 10E) belongs to
the neurotrophin subfamily of neurotrophic receptors and
exhibited a significant increase in probe-set DRG signal intensity
expression in tail amputated pigs compared with sham-handled
controls which was sustained up to 16 weeks after tail treatment
(p < 0.05). Neurotrophins are potent regulators of the survival
of different neuronal populations in the peripheral and central
nervous systems. Upon binding of its ligand neurotrophin-
3 (NTF3), NTRK3 receptors auto-phosphorylate and activate
different signaling pathways, including the phosphatidylinositol
3-kinase/AKT and the MAPK pathways that control cell survival
and differentiation. NTF3 its cognate NTRK3 receptor have been
shown to have antagonistic (anti-nociceptive) effects to NGF
in pain processing in intact neurons (88, 89) and NTF3 can
reduce an over expression of VGSCs Nav1.8 and Nav1.9 in the
DRG neurons of neuropathic rats (90) and play a role in the
modulation of neuropathic pain (91).
Interleukin receptors
Also identified within the Cluster B network of inflammatory
and neuropathic pain genes was the gene coding for the alpha
chain of the interleukin-4 receptor (IL4R: Figure 10F). DRG
probe set signal intensities for IL4R were significantly elevated
(p < 0.05) in response to tail amputation in both tail treatment
age groups compared to sham amputation control animals. The
IL4R gene codes for interleukin-4 (IL-4) alpha subunit and its is
primarily expressed by T cells, natural killer T cells, mast cells
and eosinophils, and initiates signal transduction through one of
two different (type I and II) receptor complexes type 1 receptor
is expressed on hematopoietic cells whereas type II receptors are
expressed on non-hematopoietic cells (92). The type I receptor
consists of the IL-4 R alpha and common gamma-chain/IL-2
R gamma subunits and is specific for IL-4, whereas the type
II receptor consists of the IL-4 R alpha and IL-13 R alpha 1
subunits and can be activated by either IL-4 or IL-13. IL4 is an
anti-inflammatory cytokine that exerts through its actions on
IL4 receptor complexes that module macrophage activity by the
suppression of pro-inflammatory cytokines (93, 94) and has been
shown to ameliorate neuropathic pain at the spinal level (95).
Potassium leak channel (K2P)
In contrast to the 9 down-regulated potassium channels observed
in Cluster A, a single K-type two-pore (K2P) domain potassium
leak channel gene KCNK3 was distinguished in Cluster B in
response to tail amputation (Figure 11A). KCNK3 codes for pH-
dependent, voltage-insensitive, background potassium channel
rectifier protein which acts as an outward rectifier when external
potassium concentration is low and as an inward current
rectifier when the extracellular potassium is high (96). It is well-
established that K2P channels are regulators of the excitability of
sensory neurons and therefore pain signaling (97) and regarded
as potential therapeutic targets for the treatment if pain (32). In
this studyDRGprobe-set signal intensities forKCNK3 transcripts
were significantly increased (p < 0.05) in the tail amputated pigs
compared to the sham-handled controls in both tail treatment
age cohorts and was maintained up to 16 weeks after tail
amputation injury.
Excitatory amino acid transporter
Solute carrier family 1 member 1 (SLC1A1) gene codes for
a high-affinity glutamate transporter, excitatory amino acid
transporter 1 (EAAC1), that play an essential role in transporting
glutamate across neural membranes (98). These transporters
are crucial in terminating the postsynaptic action of the
neurotransmitter glutamate, and in maintaining extracellular
glutamate concentrations below neurotoxic levels. In the present
study, DRG probe-set signal intensities for SLC1A1 transcripts
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were significantly higher in both tail amputated treatment groups
(p < 0.05) compared to their respective sham-handled controls
(Figure 11B). Maximal increases in gene probe-set intensities
in both tail treatment groups were observed 1 week after tail
treatment and appeared to attenuate thereafter but still remain
higher than controls. Studies on peripheral nerve injury in
rats indicate that glutamate transporters such as EAAC1 may
play a critical role in both the induction and maintenance of
neuropathic pain induced by peripheral nerve injury (99).
DISCUSSION
Allied to the current study we have previously demonstrated that
tail amputation in pigs is associated with significant caudal nerve
injury (complete nerve transection) and subsequent development
of traumatic neuromas in the caudal DRG neurons in the
residual tail stump (4). In addition, this is associated with
long-term hyperalgesia (lowered response thresholds to noxious
mechanical stimulation) in the tail stump (7). The results from
this transcriptomics study clearly show that tail amputation
causes marked and sustained changes in the expression of
∼3,000 genes. Characterizing which of these DRG genes are
changing and how they alter over time after tail amputation is
key to determining the likely long-term implications of these
transcriptional changes for residual stump pain.
With the quantification of many thousands of genes on the
Affymetrix porcine microarray (19,212 gene-level probe sets),
it is important to define the optimal criteria for minimizing
the false positive error rate (100). In the current study, a
FDR of 0.05 was applied to reduce the risk of generating
potential false positives to 5%. This cut off did not significantly
impact on the loss of differentially expressed genes (sensitivity)
and the sample size per group (n = 8) was appropriate for
statistical comparison. Genes for tail amputated pigs exhibiting
significant differences (p ≤ 0.05) compared to their respective
treatment age and time-matched sham controls (up and down
regulated) were subsequently investigated in the study. While, it
is recognized that the quantification of gene expression in this
study is limited to only those available on the Affymetrix chip,
a large proportion of the genes involved in inflammatory and
neuropathic pain signaling were present on the microarray and
provide an acceptable level of screening of pain-associated genes.
To the best of our knowledge, there have been no other
transcriptomics studies performed on porcine DRG neurons,
despite the emergence of the pig as a model species for preclinical
translational pain studies (101–104). Historically, pain-related
transcriptomics studies on DRG neurons have been exclusively
performed in rodents undergoing sciatic nerve crushing or
transection (axotomy) with gene expression profiling conducted
over a relatively short time (≤10 days) after nerve injury (21–
24, 105). Comparisons of the gene lists generated in this study and
those reported by others is not straightforward, not least due to
the obvious species, neuroanatomical, and treatment differences
but also by the application of different criteria used to identify
the genes, i.e., different technology platforms. However, it is
encouraging to observe that a large number of genes within
several gene families showed a consistency in their response to
peripheral nerve injury in this and other studies (21).
While, this study has shown changes in a number of genes
implicated in inflammatory and neuropathic pain pathways, it
must be recognized that peripheral nerve damage by axotomy
does not normally lead to neuropathic pain in very young
animals (106). Experimental spared nerve injury (SNI) which
causes marked mechanical allodynia and hyperalgesia which are
both key features of neuropathic pain in adult rodents, does
not typically produce equivalent responses when performed in
neonatal rat pups (107–109). However, if SNI is performed post-
natal day 33 or later does it produces comparable neuropathic
pain symptoms to those observed in older animals. Longitudinal
studies have however demonstrated that animals that experience
nerve injury early in life eventually develop pain hypersensitivity
later in life (110). These finding suggest that neuropathic pain is
not so much absent but suppressed during early development.
These experimental findings are also consistent with clinical
experience where neuropathic pain following nerve injury is
rare, although some evidence of neuropathic pain in infants has
been reported (111–114). The reason for these developmental
differences in the manifestation of neuropathic pain is not fully
understood. It has been suggested by Mckelvey et al. (115)
that the long-term painful consequences of peripheral nerve
injury in neonate animals/infants may go undetected due to
anti-inflammatory neuroimmune suppression of dorsal horn
neuronal excitation during the process of spinal somatosensory
reorganization after nerve damage. It is postulated that as an
affected animal ages, and it’s CNS matures, it’s neuroimmune
system shifts in a more pro-inflammatory direction that unmasks
latent pain responses to the nerve injury sustained early in life
and that this can emerge as clinically unexplained or functional
pain later in life (115). If the same processes occur in neonatal
tail docked piglets it may have important long-term implications
for pig health and welfare. If neuropathic pain is unmasked
in tail docked pigs in later life in commercial production
situations its effects on pig behavior may go largely unobserved
and unreported, as focus on pain-related behavior in piglets
is exclusively carried out at the time docking and a few days
afterwards (1). In addition, if tail amputated piglets eventually
develop pain hypersensitivity in the distal stump later in life the
consequences of tail biting on pain severity may be exacerbated
in older tail docked animals.
Tail amputation causes tissue trauma with associated
peripheral nerve injury that causes profound cellular stress by
depriving neurons of contact with their normal target derived
tissues which provide neurotrophic support (13). Both of these
situations trigger a variety of responses to primarily ensure
neuronal survival. In the current study, we found changes
after tail amputation in the expression of several DRG genes
associated with a neuronal survival promoting role; these include
arginase 1 (ARG1), neuritin 1 (NRN1), neuronal cell adhesion
molecule (NRCAM), netrin G2 (NTNG2), growth differentiation
factor 3 (GDF3), somatostatin (SST), neuropeptide Y (NPY)
(116). Following tail amputation, transcription factors ATF3 and
JUN were significantly up-regulated in caudal DRG neurons.
This finding is consistent with previous reports in rat DRG
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neurons after sciatic nerve transection (13, 117). It had been
suggested that these transcription factors (along with SMAD1
and STAT4) function as neuronal regeneration enhancing
factors (117). Probe-sets for SMAD1 and STAT4 were present
on the porcine array, SMAD1 exhibited significantly increased
expression in response to tail amputation, but this was not seen
for STAT4 (neither data shown). Microarray analysis of lumbar
DRG neurons after spinal nerve ligation, another commonly
used neuropathic pain model, also reported a significant increase
in ATF3 transcripts (22). It has been suggested that transcription
factors such as ATF3, JUN and SOX11 may be important in the
regulation changes in ion channel function and their accessory
subunits after peripheral nerve injury (118).
In the present study, we saw amarked effect of tail amputation
onDRGneuronal transcript expression ofmultiple types of active
and passive ion channels and transporters, in particular voltage-
dependent and two-pore domain leak potassium (K+) channels.
This observation has been widely reported in many experimental
pain studies in rodents investigating the effect of peripheral nerve
injury on the cellular and molecular mechanisms of neuropathic
pain (119–121). In DRG neurons, the membrane potential is
largely determined by potassium channels and it has been shown
that a reduction in, or loss of, function of K+ channels can
account for changes in neuronal excitability associated with
neuropathic pain states (122). Ectopic impulse generation is a key
feature of neuropathic pain and is common after peripheral nerve
damage. This spontaneous activity can be generated at the site
of nerve injury within developing traumatic neuromas, the cell
bodies (soma) of injured DRG neurons, as well is in the intact
neighboring sensory neurons (123, 124). Significant reductions in
DRG neuronal expression of genes coding for multiple voltage-
gated K+ channel subunits were observed in response to tail
amputation in the microarray study (i.e., KCNA4, KCNG4,
KCNQ3, KCNH6, KCNV1, KCNT2). The observation of a down-
regulation of these voltage-gated channel sub-unit transcripts is
consistent with a large number of reports in previous neuropathic
pain studies in rodents (22, 23, 119, 120, 125–142). In addition,
DRG neuronal transcripts for two K+ two-domain pore (K2P)
leak channels (KCNK1 and KCNK10) were also shown to be
consistently down regulated in response to peripheral nerve
resection after tail amputation. The importance of these type of
K+ channels in mediating neuronal excitability and neuropathic
pain is widely recognized (32, 143–145).
It has long been recognized that peripheral nerve injury
can bring about rapid and sustained changes in glutamate
receptor expression at various levels in sensory pathways (146–
150). In the current study, two genes GRM4 and GRM8 which
encode for metabotropic glutamate group III receptors mGluR4
and mGluR8, respectively, were persistently down-regulated in
DRG neurons after tail amputation compared to shams. This
observation is consistent with reports of down-regulation in
mGluR expression in lumbar DRG neurons in rat peripheral
axotomy model of neuropathic pain (23).
Peripheral nerve injury-induced loss of inhibition in the spinal
cord has been suggested as a mechanism that contributes to
the development of neuropathic pain. Inhibitory GABAergic
dorsal horn neurons synapse with the central terminals of
primary sensory neurons to pre-synaptically modulate primary
sensory afferent input to the CNS. The removal of GABAergic
control can lead to increase in heightened pain sensitivity (e.g.,
an exaggerated response to painful stimuli and/or response to
innocuous tactile or thermal stimuli) due to disinhibition (151),
and this has been demonstrated experimentally in a number of
rodent models of neuropathic pain following peripheral nerve
injury by complete nerve transection, chronic constriction and
part nerve ligation (142–159). In the current microarray study,
tail amputation produced a marked and sustained reduction in
the transcript expression of two ionotropic (GABRB2, GABRB3)
and two metabotropic (GABBR1, GABBR2) GABA receptor
subunits. It is clear in the present study that tail amputation
appears to not only produce changes in gene expression that
can directly affect neuronal excitability, but also affect spinal
inhibitory pathways designed to diminish peripheral sensitivity
and chronic pain.
Peripheral nerve injury involving the transection of DRG
neurons typically results in an increase in the up-regulation
of gene and protein expression of several endogenous pain
modulating neuropeptides including proenkephalin, galanin,
somatostatin, and neuropeptide Y (160–162). Probe-set
intensities for the genes that encode for these neuropeptides
(PENK, GAL, SST, and NPY, respectively) were all consistently
increased over a sustained period of time (ca. 4 months) in
porcine caudal DRG neurons in response to tail amputation.
Interestingly, although proenkephalin neuropeptide
transcripts were increased in response to peripheral nerve
injury following tail amputation, OPRM1 gene expression which
encodes for the mu opioid receptor (163) was down-regulated.
In the current study, tail amputation produced a sustained
reduction in the OPRM1 transcript expression. This observation
is consistent with number of previous studies on rodents using
a peripheral nerve transection model of neuropathic pain
which reported down-regulation in receptor mRNA and protein
expression (164) and increased tactile allodynia and mechanical
hyperalgesia in OPRM1 down-regulated animals compared
to controls in DRG and spinal cord neurons (60, 165–167).
These previous studies have all demonstrated that significant
nerve injury caused by nerve transection can lead to sustained
effects on the endogenous opioid system which negate anti-
nociceptive/analgesic effects and promote mechanical allodynia
and hyperalgesia. We have also previously demonstrated, as
part of the same study reported herein, that tail amputation in
neonatal and juvenile pigs produces a long-term mechanical
hyperalgesia (7).
A limitation of this study is that only mRNA levels were
assessed and, although transcriptional changes involving up- and
down regulation in gene expression typically (but not always)
result in concomitant increases or reductions in the encoded
protein, the magnitude of the effect can vary considerably (168).
Affymetrix microarrays, as used here, are on the whole very
specific and sensitive platforms and have been shown to compare
very favorably to RNA-seq. However, it should be recognized that
in the absence of RT-qPCR validation it is not possible to validate
the true treatment effect size (i.e., true magnitude of the gene
response) and in the absence of cellular analyses know whether
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the observed changes represent an increase in transcription of the
gene or an increase in the number of cell which express it.
The data presented in this study describes the global
response to tail injury in DRG neurons rather than focusing
upon a specific gene. Future work on this data set will
examine selected genes in isolated DRG neuron in vitro
studies in which gene expression and its encoded protein
expression will be quantified. It should also be recognized
that, in the absence of appropriate pharmacological or gene
knockout studies, it is not possible to confirm any causal
effect on post-amputation pain in any of the genes identified
in this microarray study, even though sustained mechanical
hyperalgesia in the tail stump was observed as part of
the same study (7). It should also be recognized that
the analysis approaches reported in this manuscript lacks
mechanistic validity. By presenting those differentially expressed
genes that are congruent over time and common to both
treatment age groups, it is not possible to report on any
temporal differences in gene expression within or between
treatment age groups. An analysis of the differences in the
differentially expressed genes between the treatment age groups
and across time will be conducted and reported in a future,
allied manuscript.
In addition, it is not possible to discriminate in which DRG
cell populations the effect of the peripheral nerve injury is taking
place (e.g., neurons, satellite glial cells, immune cells), although
GO enrichment analysis for cellular component indicated
that the majority of the gene expression was neuron-derived
from features such as neuron cell body, neuron projections
(neurites), axons, dendrites, and ion channel complexes and
synapses. It is also acknowledged that it was not possible
to differentiate differences between responses in injured and
non-injured caudal neurons. It is likely that some non-
injured neurons close to the site of injury and repair have
altered gene expression as a consequence of their proximity
to the inflammatory milieu; however for the purpose of
investigating the net effects of tail amputation on potential
long-term pain this does not present a problem. Similarly, it
is also not possible to discern the effect of peripheral nerve
injury on different DRG somatosensory neuron subpopulations
(e.g., nociceptive and proprioceptive afferents), although we
have previously reported preliminary data on pig tail caudal
nerve composition and shown that the caudal nerve trunks
contain a high proportion of nociceptive C and A-fibers
whose function was characterized in vitro by axonal excitability
studies (169).
CONCLUSIONS
Tail amputation in neonatal and juvenile pigs causes significant
changes in DRG gene expression (both up and down) when
compared with sham-treated intact controls and these changes
are sustained in both age groups up to 16 weeks after tail
amputation injury. Network co-expression analysis revealed
two highly correlated, interrelated DRG gene expression
profiles in response to tail amputation associated with
neurogenesis/neuronal function (Cluster A) and wound
healing (Cluster B). Gene set enrichment analysis based on the
GO terms of inflammatory and neuropathic pain identified
a high proportion of genes involved in inflammatory and
neuropathic pain signaling pathways in both expression
clusters. Key functional families of ion channels and receptors
were significantly down-regulated in Cluster A, in particular
voltage-gated potassium channels and GABA receptors which
are linked to increased neuronal excitability. Up-regulated
functional gene families in Cluster B were mostly linked
to inflammation, macrophage activity, neurohormone,
and opioid peptide activity. Tail amputation causes acute
and sustained changes in caudal DRG cells involving key
mediators of inflammatory and neuropathic pain which have
potential implications for the experience of persistent tail
stump pain.
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contains 273 transcripts upregulated following tail docking and comprising many
genes associated with response to wound healing. The functional enrichment
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Supplementary Data File 1 | Log2 fold change gene expression values (tail
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